Grail, Inc. (NASDAQ:GRAL) CEO Sells $237,976.25 in Stock

Grail, Inc. (NASDAQ:GRAL) CEO Robert P. Ragusa sold 7,625 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the sale, the chief executive officer now directly owns 828,662 shares in the company, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Grail Trading Up 10.5 %

Shares of GRAL opened at $29.74 on Friday. The stock has a fifty day moving average of $31.81 and a two-hundred day moving average of $21.29. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.

Grail (NASDAQ:GRAL) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. As a group, equities research analysts anticipate that Grail, Inc. will post -15.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Morgan Stanley assumed coverage on Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price target for the company. Wolfe Research assumed coverage on Grail in a report on Friday, November 15th. They issued a “peer perform” rating for the company.

Institutional Trading of Grail

Several large investors have recently added to or reduced their stakes in GRAL. Crcm LP acquired a new stake in Grail in the 4th quarter valued at $65,061,000. Sessa Capital IM L.P. acquired a new stake in Grail in the 4th quarter valued at $53,550,000. Primecap Management Co. CA acquired a new stake in Grail in the 4th quarter valued at $37,118,000. Baker BROS. Advisors LP acquired a new stake in Grail in the 4th quarter valued at $29,098,000. Finally, Vanguard Group Inc. purchased a new position in Grail in the 4th quarter valued at about $25,902,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.